Skip to main content
. 2022 Feb 28;28(4):704–712. doi: 10.1038/s41591-022-01694-6

Fig. 4. Changes in circulating cytokine levels from baseline to week 13 by treatment arm.

Fig. 4

Cytokine analyses were performed using n = 54 blood samples from n = 27 patients (n = 19 patients in the nivolumab–ipilimumab with CBM588 arm and n = 8 patients in the nivolumab–ipilimumab arm). Wilcoxon signed rank test was used to compare cytokine levels between the two timepoints.

Source data